Display options
Cite
Reeder JE, Sowden MP, Messing EM, et al. Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line. Cancer Cell Int. 2003;3(1):12doi: 10.1186/1475-2867-3-12.
Reeder, J. E., Sowden, M. P., Messing, E. M., Klover, P., Villa-Moruzzi, E., & Ludlow, J. W. (2003). Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line. Cancer cell international, 3(1), 12. https://doi.org/10.1186/1475-2867-3-12
Reeder, Jay E, et al. "Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line." Cancer cell international vol. 3,1 (2003): 12. doi: https://doi.org/10.1186/1475-2867-3-12
Reeder JE, Sowden MP, Messing EM, Klover P, Villa-Moruzzi E, Ludlow JW. Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line. Cancer Cell Int. 2003 Jul 23;3(1):12. doi: 10.1186/1475-2867-3-12. PMID: 12914669; PMCID: PMC183861.
Copy Download .nbib Format: NLM
Share it on

Cancer Cell Int. 2003 Jul 23;3(1):12. doi: 10.1186/1475-2867-3-12.

Inducible expression of catalytically active type 1 serine/threonine protein phosphatase in a human carcinoma cell line.

Cancer cell international

Jay E Reeder, Mark P Sowden, Edward M Messing, Peter Klover, Emma Villa-Moruzzi, John W Ludlow

Affiliations

  1. Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, New York, 14642, USA. [email protected]

PMID: 12914669 PMCID: PMC183861 DOI: 10.1186/1475-2867-3-12

Abstract

BACKGROUND: One of the major cellular serine/threonine protein phosphatases is protein phosphatase type 1 (PP1). Studies employing many eukaryotic systems all point to a crucial role for PP1 activity in controlling cell cycle progression. One physiological substrate for PP1 appears to be the product of the retinoblastoma susceptibility gene (pRB), a demonstrated tumor suppressor. The growth suppressive activity of pRB is regulated by its phosphorylation state. Of critical importance is the question of the in vivo effect of PP1 activity on pRB and growth regulation. As a first step towards addressing this question, we developed an inducible PP1 expression system to investigate the regulation of PP1 activity. RESULTS: We have established a cell line for inducing protein expression of the type 1, alpha-isotype, serine/threonine protein phosphatase (PP1alpha). A plasmid encoding a fusion protein of the catalytic subunit of PP1alpha with a 6-histidine peptide (6His) and a peptide from hemagluttinin (HA) was transfected into the UMUC3 transitional cell carcinoma cell line, previously transfected with the reverse tetracycline transactivator plasmid pUHD172-1neo. A stable cell line designated LLWO2F was established by selection with hygromycin B. 6His-HA-PP1alpha protein appeared in cell lysates within two hours following addition of doxycycline to the culture medium. This protein localizes to the nucleus as does endogenous PP1alpha, and was shown to associate with PNUTS, a PP1-nuclear targeting subunit. Like endogenous PP1alpha, immunocomplexed 6His-HA-PP1alpha is active toward phosphorylase a and the product of the retinoblastoma susceptibility gene, pRB. When forcibly overexpressing 6His-HA-PP1alpha, there is a concomitant decrease in endogenous PP1alpha levels. CONCLUSIONS: These data suggest the existence of an autoregulatory mechanism by which PP1alpha protein levels and activity remain relatively constant. RT-PCR analyses of isolated polysome fractions support the notion that this putative autoregulatory mechanism is exerted, at least in part, at the translational level. Implications of these findings for the study of PP1alpha function in vivo are discussed.

References

  1. Semin Cancer Biol. 1995 Aug;6(4):195-202 - PubMed
  2. J Biol Chem. 1992 Jan 25;267(3):1484-90 - PubMed
  3. Science. 1983 Jul 22;221(4608):331-8 - PubMed
  4. J Cell Biol. 1998 Jun 1;141(5):1207-15 - PubMed
  5. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
  6. Eur J Biochem. 1990 Jun 20;190(2):291-7 - PubMed
  7. J Cell Biol. 1992 Mar;116(6):1421-30 - PubMed
  8. Curr Opin Cell Biol. 1996 Dec;8(6):805-14 - PubMed
  9. Annu Rev Biochem. 1989;58:453-508 - PubMed
  10. Genes Dev. 1993 Apr;7(4):555-69 - PubMed
  11. Methods Enzymol. 1988;159:390-408 - PubMed
  12. J Biol Chem. 1997 Feb 14;272(7):4528-35 - PubMed
  13. Cell. 1990 Oct 19;63(2):405-15 - PubMed
  14. Science. 1992 Oct 16;258(5081):424-9 - PubMed
  15. Curr Biol. 1997 Jun 1;7(6):375-86 - PubMed
  16. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):388-92 - PubMed
  17. Biochem J. 1995 Oct 1;311 ( Pt 1):17-29 - PubMed
  18. Cell. 1989 Sep 22;58(6):1193-8 - PubMed
  19. Cell. 1990 Feb 9;60(3):387-96 - PubMed
  20. Physiol Rev. 1993 Oct;73(4):673-99 - PubMed
  21. Cell. 1989 Jun 16;57(6):891-3 - PubMed
  22. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4 - PubMed
  23. EMBO J. 1994 Nov 15;13(22):5310-8 - PubMed
  24. J Biol Chem. 1998 Jul 24;273(30):19019-24 - PubMed
  25. Science. 1995 Jun 23;268(5218):1766-9 - PubMed
  26. Biochem Biophys Res Commun. 1993 May 14;192(3):1289-96 - PubMed
  27. Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3953-7 - PubMed
  28. Mol Cell Biol. 1993 Jan;13(1):367-72 - PubMed
  29. Cell. 1989 Sep 22;58(6):1085-95 - PubMed
  30. Cell. 1989 Sep 22;58(6):1097-105 - PubMed
  31. Methods Mol Biol. 1998;93:169-83 - PubMed
  32. FEBS Lett. 1992 Jun 15;304(2-3):211-5 - PubMed
  33. Oncogene. 1997 May 22;14(20):2407-15 - PubMed
  34. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  35. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6408-12 - PubMed
  36. Biochem J. 1988 Nov 15;256(1):283-90 - PubMed
  37. J Biol Chem. 1998 Feb 13;273(7):4089-95 - PubMed
  38. Methods Mol Biol. 1998;93:35-40 - PubMed

Publication Types